KEGG   DRUG: D09819Help
Entry
D09819                      Drug                                   

Name
Chlorpromazine tannate (JAN)
Remark
ATC code: 
Drug group: 
Target
5-HT2-receptor antagonist [HSA:3356 3357 3358] [KO:K04157];
H1-receptor antagonist [HSA:3269] [KO:K04149];
alpha2-adrenergic receptor antagonist [HSA:150 151 152] [KO:K04138 K04139 K04140];
dopamine D2-receptor antagonist [HSA:1813] [KO:K04145];
muscarinic cholinergic receptor antagonist [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04726  Serotonergic synapse
hsa04728  Dopaminergic synapse  
 
Metabolism
Enzyme: CYP2D6 [HSA:1565]
Interaction
CYP inhibition: CYP2D6 [HSA:1565]
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N05 PSYCHOLEPTICS
   N05A ANTIPSYCHOTICS
    N05AA Phenothiazines with aliphatic side-chain
     N05AA01 Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Acetylcholine (muscarinic)
    muscarinic cholinergic receptor
     Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
   Adrenaline
    alpha2-adrenergic receptor
     Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
   Dopamine
    dopamine D2-receptor
     Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
   Histamine
    H1-receptor
     Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
   Serotonin
    5-HT2-receptor
     Chlorpromazine
      D09819  Chlorpromazine tannate (JAN)
Cytochrome P450 interactions [BR:br08309]
 Substrates
  CYP2D6
   Chlorpromazine
    D09819  Chlorpromazine tannate (JAN)
 Inhbitors
  CYP2D6
   Chlorpromazine
    D09819  Chlorpromazine tannate (JAN)
BRITE hierarchy
Other DBs
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system